BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Coagulation
,
Leukemia
,
Endothelial cell
,
Pharmacogenetics
,
Lipitor
,
rs2300478
,
BRCA1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
poly adp)- ribosylated proteins
Summary
General Info
Curated Studies
Most Correlated Studies
COLO320DM, ABC-1, U031, OVCAR-4, and RKO cells treated with TNKS1 and TNKS2 inhibitor G007-LK
Breast luminal 226LDM cells arrested in the cell cycle with hydroxyurea and nocodazole
Acute lymphoblastic leukemia expression profiles of different karyotypic subtypes
Explore Curated Studies Results
Literature
Most Relevant Literature
Gold nanoparticles based colorimetric assay of protein poly(ADP-ribosyl)ation.
The recognition and removal of cellular poly(ADP-ribose) signals.
The pioneering spirit of Takashi Sugimura: his studies of the biochemistry of poly(ADP-ribosylation)…
NAD+ depletion or PAR polymer formation: which plays the role of executioner in ischaemic cell death…
Detection and quantification of poly-ADP-ribosylated cellular proteins of spleen and liver tissues o…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Veliparib in Combination With Gemcitabine and Intensity Modulated Radiation Therapy in Patients With…
ABT-888 Plus Metronomic Cyclophosphamide to Treat Cancer
Safety Study of ABT-888 Plus Topotecan Hydrochloride to Treat Patients With Solid Tumors and Lymphom…
Expanded Access With ABT-888 (Veliparib) to Treat Metastatic Breast Cancer
Veliparib (ABT-888), an Oral PARP Inhibitor, and VX-970, an ATR Inhibitor, in Combination With Cispl…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ